四川百利天恒药业股份有限公司关于股份回购进展公告

Group 1 - The company has approved a share repurchase plan using its own and/or self-raised funds, with a total repurchase amount not less than RMB 100 million and not exceeding RMB 200 million, to be used for employee stock ownership plans or equity incentives [2] - The maximum repurchase price is set at RMB 546 per share, and the repurchase period is within 12 months from the board's approval date [2] - As of January 31, 2026, the company has repurchased a total of 321,398 shares, accounting for 0.08% of the total share capital, with a total expenditure of RMB 99.85 million [3] Group 2 - The company will comply with relevant regulations and make repurchase decisions based on market conditions, ensuring timely information disclosure regarding the progress of the share repurchase [5]